Gene electrotransfer: Potential for gene therapy of renal diseases

Slides:



Advertisements
Similar presentations
Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Pathophysiology of renal fluid retention
Renal manifestations in Fabry disease and therapeutic options
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
Progression of renal failure and hypertensive nephrosclerosis
Volume 77, Issue 1, Pages 6-8 (January 2010)
Ralph Witzgall, Bettina Kränzlin, Norbert Gretz, Nicholas Obermüller 
Pathophysiology of renal fluid retention
Haiyan Wang, Luxia Zhang, Jicheng Lv  Kidney International 
Francesco Paolo Schena  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Chimeric RNA/DNA oligonucleotide-based gene therapy
George A. Kaysen, Burl R. Don
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Lipid redistribution in renal dysfunction
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Volume 74, Issue 5, Pages (September 2008)
Study of Heart and Renal Protection (SHARP)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
Volume 76, Issue 6, Pages (September 2009)
New insights in uremic toxins
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Winfried Siffert  Kidney International 
Nephrology in Latin America, with special emphasis on Brazil
Future of icodextrin as an osmotic agent in peritoneal dialysis
AGEs in foods: Do they play a role in uremia?
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Volume 87, Issue 1, Pages (January 2015)
Counteracting progression of renal disease: A look into the future
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Unilateral renal cystic disease
Homocysteine, renal function, and risk of cardiovascular disease
Proteinuria screening for children
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Clinical benefits of slowing the progression of renal failure
Volume 70, Pages S84-S90 (November 2006)
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Volume 83, Issue 4, Pages (April 2013)
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Volume 56, Pages S28-S30 (July 1999)
Effect of lipid-lowering strategies on tubular cell biology
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Volume 70, Issue 3, Pages (August 2006)
86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy    Molecular Therapy  Volume 20, Pages S35-S36.
T cells and T-cell receptors in acute renal failure
Renal vascular disease in the elderly
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Shirley Wong, Roderick A. Slavcev
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Gene electrotransfer: Potential for gene therapy of renal diseases Enyu Imai, Yoshitaka Isaka  Kidney International  Volume 61, Issue 1, Pages S37-S41 (January 2002) DOI: 10.1046/j.1523-1755.2002.0610s1037.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Possible mechanisms of DNA transfer by electroporation.A The membrane becomes extremely conductive, and the current lines pass through the inside of the cell when the electric field is intensified to certain limit. Pore formation by electrical breakdown, electroporation, is accomplished (top). Only the DNA bound to the membrane is transferred to the inside (bottom). Some mechanism to move the DNA toward the pore has been suggested.(B) The electric pulse causes membrane instability (top). The instability of the lipid bilayer results in formation of vesicles containing DNA. The DNA included in the lipid vesicles is endocytosed, and the DNA is transferred to cytosol (bottom). Kidney International 2002 61, S37-S41DOI: (10.1046/j.1523-1755.2002.0610s1037.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Possible mechanisms of DNA transfer by electroporation.A The membrane becomes extremely conductive, and the current lines pass through the inside of the cell when the electric field is intensified to certain limit. Pore formation by electrical breakdown, electroporation, is accomplished (top). Only the DNA bound to the membrane is transferred to the inside (bottom). Some mechanism to move the DNA toward the pore has been suggested.(B) The electric pulse causes membrane instability (top). The instability of the lipid bilayer results in formation of vesicles containing DNA. The DNA included in the lipid vesicles is endocytosed, and the DNA is transferred to cytosol (bottom). Kidney International 2002 61, S37-S41DOI: (10.1046/j.1523-1755.2002.0610s1037.x) Copyright © 2002 International Society of Nephrology Terms and Conditions